Adenovirus delivery of human CD40 ligand gene confers direct therapeutic effects on carcinomas.

Vardouli, L; Lindqvist, C; Vlahou, K; Loskog, A S I; Eliopoulos, A G

Vardouli, L; Lindqvist, C; Vlahou, K; Loskog, A S I; Eliopoulos, A G.

Affiliation

Vardouli L; Molecular and Cellular Biology Laboratory, Division of Basic Sciences, University of Crete Medical School, Heraklion, Crete 71003, Greece.

Cancer Gene Ther ; 16(11): 848-60, 2009 Nov.

Article in En | MEDLINE | ID: mdl-19461675

Subject(s)

Adenoviridae/genetics; CD40 Ligand/genetics; CD40 Ligand/metabolism; CD40 Ligand/physiology; Carcinoma/therapy; Genetic Therapy/methods; Animals; Antineoplastic Agents/therapeutic use; Apoptosis/physiology; Cell Line, Tumor; Cell Proliferation/drug effects; Cisplatin/therapeutic use; Flow Cytometry; Fluorouracil/therapeutic use; Humans; Immunoblotting; Mice; Mice, Nude; Mitomycin/therapeutic use; Xenograft Model Antitumor Assays

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma / Genetic Therapy / Adenoviridae / CD40 Ligand Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Cancer Gene Ther Journal subject: GENETICA MEDICA / NEOPLASIAS / TERAPEUTICA Year: 2009 Document type: Article Affiliation country: Greece Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google